Suyash Prasad
CIK 1679129 · View on SEC EDGAR ↗
First SEC filing: Sept. 23, 2020 · Latest: Sept. 23, 2020
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| July 6, 2022 | TSHA | S 10b5-1 | 8,956 | $3.79 | $33,943 | 530,589 Direct | -1.66% | Disposed | 60.9% (price as of 2026-08-20) |
| July 5, 2022 | TSHA | S 10b5-1 | 3,905 | $3.51 | $13,707 | 539,545 Direct | -0.72% | Disposed | 73.8% (price as of 2026-08-20) |
| July 1, 2022 | TSHA | S 10b5-1 | 23,923 | $3.53 | $84,448 | 543,450 Direct | -4.22% | Disposed | 72.8% (price as of 2026-08-20) |
| June 30, 2022 | TSHA | S 10b5-1 | 13,892 | $3.72 | $51,678 | 567,373 Direct | -2.39% | Disposed | 64.0% (price as of 2026-08-20) |
| June 29, 2022 | TSHA | S 10b5-1 | 12,324 | $3.81 | $46,954 | 581,265 Direct | -2.08% | Disposed | 60.1% (price as of 2026-08-20) |
| July 1, 2021 | TSHA | S 10b5-1 | 19,706 | $21.12 | $416,191 | 593,589 Direct | -3.21% | Disposed | -71.1% (price as of 2026-08-20) |
| June 30, 2021 | TSHA | S 10b5-1 | 13,374 | $21.42 | $286,471 | 619,997 Direct | -2.11% | Disposed | -71.5% (price as of 2026-08-20) |
| June 30, 2021 | TSHA | S 10b5-1 | 6,202 | $22.44 | $139,173 | 613,795 Direct | -1.00% | Disposed | -72.8% (price as of 2026-08-20) |
| June 30, 2021 | TSHA | S 10b5-1 | 500 | $23.70 | $11,850 | 613,295 Direct | -0.08% | Disposed | -74.3% (price as of 2026-08-20) |
| June 29, 2021 | TSHA | S 10b5-1 | 35,056 | $23.74 | $832,229 | 637,533 Direct | -5.21% | Disposed | -74.3% (price as of 2026-08-20) |
| June 29, 2021 | TSHA | S 10b5-1 | 3,862 | $24.46 | $94,465 | 633,671 Direct | -0.61% | Disposed | -75.1% (price as of 2026-08-20) |
| June 29, 2021 | TSHA | S 10b5-1 | 300 | $25.19 | $7,557 | 633,371 Direct | -0.05% | Disposed | -75.8% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| April 6, 2022 | TSHA | Employee Stock Option (right to buy) | Common Stock (40,325) | $6.52 | April 6, 2032 | 40,325 | Acquired |
| Feb. 23, 2022 | TSHA | Employee Stock Option (right to buy) | Common Stock (80,650) | $5.96 | Feb. 23, 2032 | 80,650 | Acquired |
| Jan. 19, 2021 | TSHA | Stock Option (Right to Buy) | Common Stock (80,000) | $31.00 | Jan. 19, 2031 | 80,000 | Acquired |
| Sept. 28, 2020 | TSHA | Series B Preferred Stock | Common Stock (3,844) | — | — | 3,529 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Sept. 23, 2020 | TSHA | Series B Preferred Stock→ Common Stock (3,844) | 3,844 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
TSHA
M.B.B.S, F.F.P.M. Chief Medical Officer and Head of Research and Development| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2021 | $432,600 | — | — | — | $181,692 | — | $3,051 | $2,231,064 |
| 2020 | $216,833 | — | — | — | $129,975 | — | $152 | $4,015,369 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.